ArticleCancer2021
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
Michael Cecchini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it